Advanced Filter

Filter by Group

Filter by Market Availability

Did you mean 3.2.1 20 7?
Displaying drugs 8576 - 8600 of 9159 in total
Experimental
Matched Name: … 4-(dihydroxyboranyl)-2-({[4-(phenylsulfonyl)thiophen-2-yl]sulfonyl}amino)benzoic acid …
Matched Iupac: … 2-[4-(benzenesulfonyl)thiophene-2-sulfonamido]-4-(dihydroxyboranyl)benzoic acid …
Experimental
Matched Synonyms: … 2-acetamidopropionic acid ... (S)-2-(acetylamino)propanoic acid …
Matched Iupac: … (2S)-2-acetamidopropanoic acid …
Experimental
Matched Synonyms: … Japanese encephalitis live attenuated strain sa 14-14-2 antigen ... Japanese encephalitis live attenuated strain sa 14-14-2 vaccine …
Experimental
Matched Name: … D-phenylalanyl-N-(3-chlorobenzyl)-L-prolinamide …
Matched Iupac: … (2S)-1-[(2R)-2-amino-3-phenylpropanoyl]-N-[(3-chlorophenyl)methyl]pyrrolidine-2-carboxamide …
Experimental
Matched Name: … 3-Amino-4,5-Dihydroxy-Cyclohex-1-Enecarboxylate …
Matched Iupac: … (3S,4R,5R)-3-amino-4,5-dihydroxycyclohex-1-ene-1-carboxylate …
3-fluoro-N-1H-indol-5-yl-5-morpholin-4-ylbenzamide is a solid. This compound belongs to the phenylmorpholines. These are aromatic compounds containing a morpholine ring and a benzene ring linked to each other through a CC or a CN bond. This drug targets mitogen-activated protein kinase 14.
Experimental
Matched Name: … 3-fluoro-N-1H-indol-5-yl-5-morpholin-4-ylbenzamide …
Matched Iupac: … 3-fluoro-N-(1H-indol-5-yl)-5-(morpholin-4-yl)benzamide …
Matched Description: … 3-fluoro-N-1H-indol-5-yl-5-morpholin-4-ylbenzamide is a solid. …
Experimental
Matched Name: … 1-CHLORO-6-(4-HYDROXYPHENYL)-2-NAPHTHOL …
Matched Iupac: … 1-chloro-6-(4-hydroxyphenyl)naphthalen-2-ol …
Experimental
Matched Name: … 2-aminoethyl naphthalen-1-ylacetate …
Matched Iupac: … 2-aminoethyl 2-(naphthalen-1-yl)acetate …
Experimental
Matched Name: … 2-((4'-HYDROXYNAPHTHYL)-AZO)BENZOIC ACID …
Matched Iupac: … 2-[(1E)-2-(4-hydroxynaphthalen-1-yl)diazen-1-yl]benzoic acid …
Experimental
Matched Name: … 4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid …
Matched Iupac: … 4-[hydroxy(methyl)phosphoryl]-3-oxobutanoic acid …
Experimental
Matched Name: … 4-(Acetylamino)-3-[(Aminoacetyl)Amino]Benzoic Acid …
Matched Iupac: … [(5-carboxy-2-acetamidophenyl)carbamoyl]methanaminium …
Experimental
Matched Name: … 3-Aminomethyl-Pyridinium-Adenine-Dinucleotide …
Matched Iupac: … }oxy)(hydroxy)phosphoryl]oxy}methyl)-3,4-dihydroxyoxolan-2-yl]-3-(aminomethyl)-1lambda5-pyridin-1-ylium ... 1-[(2R,3R,4S,5R)-5-({[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphonato …
Experimental
Matched Name: … 3-[(9H-fluoren-9-ylideneamino)oxy]propanoic acid …
Matched Iupac: … 3-{[(9H-fluoren-9-ylidene)amino]oxy}propanoic acid …
Experimental
Matched Name: … N-(4-sulfamoylphenyl)-1H-indazole-3-carboxamide …
Matched Iupac: … N-(4-sulfamoylphenyl)-1H-indazole-3-carboxamide …
GS-6620 is under investigation in clinical trial NCT01316237 (A Study Evaluating the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of GS-6620 in Treatment Naïve Subjects With Chronic Hepatitis C Virus Infection).
Investigational
Matched Iupac: … -4-methyl-3-[(2-methylpropanoyl)oxy]oxolan-2-yl]methoxy}(phenoxy)phosphoryl]amino}propanoate ... propan-2-yl (2S)-2-{[(S)-{[(2R,3R,4R,5R)-5-{4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl}-5-cyano-4-hydroxy …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
Experimental
Matched Name: … 2-Phenylamino-Ethanesulfonic Acid …
Matched Iupac: … 2-(phenylamino)ethane-1-sulfonic acid …
Experimental
Matched Iupac: … {[(2S,3S,4S,5R)-3,4-dihydroxy-5-[(phosphonooxy)methyl]oxolan-2-yl]methoxy}phosphonic acid …
Experimental
Matched Name: … 4-(2-AMINOETHYL)BENZENESULFONAMIDE …
Matched Iupac: … 4-(2-aminoethyl)benzene-1-sulfonamide …
Sibeprenlimab is under investigation in clinical trial NCT05248659 (Phase 2/3 Open-label Trial of Sibeprenlimab in the Treatment of Immunoglobulin a Nephropathy).
Investigational
Matched Synonyms: … Immunoglobulin g2, anti-(human proliferation-inducing ligand protein) (human monoclonal vis649 .gamma.2- …
Matched Description: … Sibeprenlimab is under investigation in clinical trial NCT05248659 (Phase 2/3 Open-label Trial of Sibeprenlimab …
Experimental
Matched Name: … 4-(Carboxyvin-2-Yl)Phenylboronic Acid …
Matched Iupac: … (2E)-3-[4-(dihydroxyboranyl)phenyl]prop-2-enoic acid …
Experimental
Matched Iupac: … (2R,3R,4S,5R,6S)-3,4,6-trihydroxy-5-(sulfooxy)oxane-2-carboxylic acid …
Experimental
Matched Name: … 2-[(Dioxidophosphoranyl)oxy]benzoate …
Matched Iupac: … 2-[(oxidophosphonoyl)oxy]benzoate …
Experimental
Matched Name: … 2-(4-METHYLPHENOXY)ETHYLPHOSPHINATE …
Matched Iupac: … [2-(4-methylphenoxy)ethyl]phosphinate …
BNT162b1 is one of four advanced mRNA-based vaccines being developed through "Project Lightspeed," a joint program between Pfizer and BioNTech.[L15002, L15007] BNT162b1 is a nucleoside modified mRNA (modRNA) vaccine encoding the receptor-binding domain (RBD) of the SARS-CoV-2 spike (S) protein together with a "foldon" trimerization domain derived from T4 fibritin...
Investigational
Matched Name: … BNT162b1 SARS-CoV-2 Vaccine …
Matched Description: … nucleoside modified mRNA (modRNA) vaccine encoding the receptor-binding domain (RBD) of the SARS-CoV-2 ... [L15007, L15012] Early results from a phase 1/2 study in 45 healthy adult volunteers demonstrated RBD-binding …
Displaying drugs 8576 - 8600 of 9159 in total